Scientific Research News

BOSTON--(BUSINESS WIRE)--PureTech Health: Results of Annual General Meeting...

MUNICH & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Snke and Precision NeuroMed announce partnership to streamline and scale precision drug delivery to the brain through digital workflow orchestration....

TOKYO--(BUSINESS WIRE)--OKI (TOKYO:6703) has been selected as the representative organization for the technology development project titled “Development and Global Deployment of a Next-Generation Infrastructure Monitoring System Through Close Integration of Satellites and Ground Sensors,” proposed jointly with LTS, Inc. (Head office: Minato-ku, Tokyo; President and Representative Director: Hiroaki Kabashima; “LTS”). The project comes under the technology development theme “Acceleration of Imple...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, leading developer of AI models for tumor and immune biology, today announced its participation at the 22nd Annual Industry/Academia Precision Oncology & RadMed Symposium. At this premier event, global leaders in life sciences will explore the latest innovations in AI, immuno-oncology, molecular imaging, and targeted therapies. The symposium will be held on Thursday, June 11, 2026, at The Alexandria at Torrey Pines Conference Center in San Diego,...

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle Education today announced its K–2 Nuclear Energy Program has been named the “Overall STEM Education Solution of the Year” in the 2026 EdTech Breakthrough Awards. The recognition underscores Battelle Education’s role as a national leader in expanding access to high-quality, workforce-aligned STEM learning. The annual EdTech Breakthrough Awards honor standout solutions across the global education technology sector. Battelle Education earned this top recog...

CHICAGO--(BUSINESS WIRE)--The Institute of Food Technologists (IFT), a nonprofit scientific association committed to advancing the science of food and its application across the global food system, will host an interactive community conversation on “What the Latest Food Policy Debates Mean for the Food System” on Wednesday, June 17, from 12:00 p.m. – 1:00 p.m. CT. Free and open to the public, the Community Conversation is based on the recent House Energy & Commerce Subcommittee on Health he...

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics®, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today announced the expansion of its mammalian cell culture capabilities with the addition of cell line development services, strengthening its ability to provide a seamless path from DNA to IND submission for its customers. The launch of new cell line development services reflects Cytovance’s continued investment in innovati...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the world's first Integrated Development and Manufacturing Organization (IDMO) dedicated to automated cell therapy production, announced today it has joined the New American Industrial Alliance (NAIA), a coalition committed to rebuilding America's strategic industrial base and restoring domestic manufacturing leadership. Cellares joins NAIA as part of its mission to help establish a resilient, sovereign U.S. biomanufacturing ecosystem capa...

CAMBRIDGE, Mass. & PAMPLONA, Spain--(BUSINESS WIRE)--Predicta Biosciences, a company building ultra-sensitive molecular and immune diagnostic platforms, and CIMA LAB Diagnostics from the Clínica Universidad de Navarra, a leading European University Medical Center, today announced a partnership to offer a combined service that integrates CIMA LAB’s flow cytometry capabilities with the GenoPredicta™ assay. The offering will be available to academic institutions and biopharma across Spain and the...

LA JOLLA, Calif.--(BUSINESS WIRE)--The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development arm of Scripps Research, today announced two milestones in the clinical advancement of CLF065, its potential best-in-class, long-acting glucagon-like peptide-2 (GLP-2) receptor agonist in development for inflammatory bowel diseases (IBD). Calibr-Skaggs has enrolled the first patient in its Phase 2 study of CLF065 in chronic pouchitis and has filed an Investigational New Drug (...